← Back to Search

Brief Enhanced Anxiety Sensitivity Treatment (Group BEAST) for Anxiety Sensitivity (Group BEAST Trial)

N/A

Waitlist Available

Research Sponsored by Ohio University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, post-treatment including emi (2 weeks after the session), 1 month follow-up.

Awards & highlights

Group BEAST Trial Summary

This trial is testing whether adding real-time, personalized intervention messages to a one-session virtual treatment for anxiety sensitivity (BEAST) will improve the efficacy of the treatment in reducing anxiety.

Eligible Conditions

Anxiety Sensitivity
Anxiety

Group BEAST Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, post-treatment including emi (2 weeks after the session), 1 month follow-up.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, post-treatment including emi (2 weeks after the session), 1 month follow-up.

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post-treatment including emi (2 weeks after the session), 1 month follow-up. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Anxiety Sensitivity Inventory-3 (ASI-3; Taylor et al., 2007)

Change in PROMIS Anxiety scale - 8a

Secondary outcome measures

Anxiety

Daily change - PROMIS Anxiety Short Form 8a Modified (all participants)

Anxiety

Other outcome measures

COVID-19 impact battery short-form

Change in PROMIS Depression scale - 8a

Change in PROMIS Psychological Stress scale - 8a

+1 more

Group BEAST Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: EMI groupExperimental Treatment1 Intervention

For two weeks after the intervention session, participants will report on their anxiety level four times per day. When participants endorse elevated anxiety, they will receive a message relevant to their most stressful symptom at the moment reminding them of the topics covered in the intervention session. As the efficacy of the EMI component is being tested, only the EMI group will receive EMI.

Group II: Control groupActive Control1 Intervention

The control group will not receive EMI prompts and will be offered to complete EMI after the follow-up assessment.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Brief Enhanced Anxiety Sensitivity Treatment (Group BEAST)

2022

N/A

~80

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Ohio UniversityLead Sponsor

69 Previous Clinical Trials

37,141 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are involved in this investigation?

"Affirmative. According to the information found on clinicaltrials.gov, this medical trial which was first advertised in February 9th 2022 is currently enrolling patients and seeking 75 volunteers from a single site. The post has been recently updated on July 10th 2022."

Answered by AI

Are there any vacancies available in this investigation?

"The clinicaltrial.gov website reveals that this trial is still scouting participants, having been posted on February 9th 2022 and updated lastly around July 10th of the same year."

Answered by AI